X4 Pharmaceuticals to Participate in Two May Virtual Investor Conferences

NEXT STORY
Predictmedix Announces Technology Deployment at Hockeyfest in Partnership With Jones Entertainment Group
PREV STORY
Black Diamond Therapeutics to Host Webcast Presentation of Data From Phase 1 Dose-Escalation Portion of MasterKey-01 Clinical Trial
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

AIM Announces Milestone in COVID-19 Treatment and Prevention Efforts with First Patient Dosed in Study Evaluating Ampligen as Part of Combination Treatment for Patients with Cancer and COVID-19

author_avatar
NASDAQ Market News

Point of Care Testing for Infectious Diseases Market to hit US $2.2 billion by 2025 – Global Insights on Trends, Value Chain Analysis, Regulatory Framework, Drivers, and Future Prospect: Adroit Market Research

author_avatar
NASDAQ Market News

Chiasma Reports Third Quarter 2017 Results

WALTHAM, Mass., Nov. 09, 2017 (GLOBE NEWSWIRE) -- Chiasma, Inc. (NASDAQ:CHMA), a clinical-stage biopharmaceutical ...

author_avatar
NASDAQ Market News